132 related articles for article (PubMed ID: 38261153)
1. Validating the usefulness of Sudoscan in ATTRv: a single centre experience.
Moreno-Moraleda E; González-Moreno J; Cisneros-Barroso E; Ribot-Sansó MA; Ripoll-Vera T; Descals C; Uson M; Montalà JC; Figuerola A; Rodríguez A; Losada I
Neurol Sci; 2024 Jun; 45(6):2859-2867. PubMed ID: 38261153
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
[TBL] [Abstract][Full Text] [Related]
3. Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study.
Sahuc P; Chiche L; Dussol B; Pouget J; Franques J
Ther Clin Risk Manag; 2016; 12():135-8. PubMed ID: 26893567
[TBL] [Abstract][Full Text] [Related]
4. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
[TBL] [Abstract][Full Text] [Related]
5. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
Fortanier E; Delmont E; Verschueren A; Attarian S
Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
[TBL] [Abstract][Full Text] [Related]
6. Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience.
Romano A; Guglielmino V; Di Paolantonio A; Bisogni G; Sabatelli M; Della Marca G; Minnella AM; Maceroni M; Bellavia S; Scala I; Sabatelli E; Rollo E; Luigetti M
Amyloid; 2022 Dec; 29(4):270-275. PubMed ID: 36066019
[TBL] [Abstract][Full Text] [Related]
7. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction.
Casellini CM; Parson HK; Richardson MS; Nevoret ML; Vinik AI
Diabetes Technol Ther; 2013 Nov; 15(11):948-53. PubMed ID: 23889506
[TBL] [Abstract][Full Text] [Related]
8. Dual-Echo Turbo Spin Echo and 12-Echo Multi Spin Echo Sequences as Equivalent Techniques for Obtaining T2-Relaxometry Data: Application in Symptomatic and Asymptomatic Hereditary Transthyretin Amyloidosis as a Surrogate Disease.
Poncelet A; Weiler M; Hegenbart U; Sam G; Schönland S; Purrucker JC; Hayes JM; Hund E; Bendszus M; Heiland S; Kollmer J
Invest Radiol; 2022 May; 57(5):301-307. PubMed ID: 34839307
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
González-Moreno J; Gragera-Martínez Á; Rodríguez A; Borrachero-Garro C; García-Garrido S; Barceló C; Manovel-Sánchez A; Ribot-Sansó MA; Ibargüen-González L; Gomila R; Muñoz-Beamud F; Losada-López I; Cisneros-Barroso E
Sci Rep; 2024 Jan; 14(1):581. PubMed ID: 38182630
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Body Scan
Riveline JP; Mallone R; Tiercelin C; Yaker F; Alexandre-Heymann L; Khelifaoui L; Travert F; Fertichon C; Julla JB; Vidal-Trecan T; Potier L; Gautier JF; Larger E; Lefaucheur JP
Front Neurol; 2023; 14():1256984. PubMed ID: 38020587
[TBL] [Abstract][Full Text] [Related]
11. Electrochemical Skin Conductance by Sudoscan in Non-Dialysis Chronic Kidney Disease Patients.
Chiu LT; Lin YL; Wang CH; Hwu CM; Liou HH; Hsu BG
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202194
[TBL] [Abstract][Full Text] [Related]
12. Assessment of sudomotor function in hypertensive with/without type-2 diabetes patients using SUDOSCAN: An electrophysiological study.
Hussein II; Alshammary SHA; Al-Nimer MSM
Clin Neurophysiol Pract; 2021; 6():22-28. PubMed ID: 33490739
[TBL] [Abstract][Full Text] [Related]
13. Normal values of sudomotor function assessed by electrochemical skin conductance in African population.
Lare BP; Jost J; Apetse K; Salle L; Preux PM; Balogou A; Magne J
Rev Neurol (Paris); 2024 Mar; 180(3):163-170. PubMed ID: 37813768
[TBL] [Abstract][Full Text] [Related]
14. Sudomotor Testing of Diabetes Polyneuropathy.
Krieger SM; Reimann M; Haase R; Henkel E; Hanefeld M; Ziemssen T
Front Neurol; 2018; 9():803. PubMed ID: 30319533
[No Abstract] [Full Text] [Related]
15. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
[TBL] [Abstract][Full Text] [Related]
16. Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy.
Duchesne M; Richard L; Vallat JM; Magy L
Clin Neurophysiol; 2018 Jul; 129(7):1341-1348. PubMed ID: 29729587
[TBL] [Abstract][Full Text] [Related]
17. Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.
Saad M; Psimaras D; Tafani C; Sallansonnet-Froment M; Calvet JH; Vilier A; Tigaud JM; Bompaire F; Lebouteux M; de Greslan T; Ceccaldi B; Poirier JM; Ferrand FR; Le Moulec S; Huillard O; Goldwasser F; Taillia H; Maisonobe T; Ricard D
J Neurooncol; 2016 Apr; 127(2):373-80. PubMed ID: 26749101
[TBL] [Abstract][Full Text] [Related]
18. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience.
Luigetti M; Di Paolantonio A; Guglielmino V; Romano A; Rossi S; Sabino A; Servidei S; Sabatelli M; Primiano G
Neurol Sci; 2022 Apr; 43(4):2845-2848. PubMed ID: 35094171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
